AnPac Bio-Medical Science Co Ltd - ADR

NASDAQ:ANPC   12:17:13 PM EDT
3.78
-0.09 (-2.33%)
Earnings Announcements

Anpac Bio Reports Qtrly Loss Per Share RMB 2.43

Published: 05/27/2021 11:01 GMT
AnPac Bio-Medical Science Co Ltd - ADR (ANPC) - Anpac Bio Reports Strong First Quarter in 2021, With 137.2% Increase in Revenue and Record Number of Commercial Tests Completed.
Q1 Revenue Rose 137.2 Percent to Rmb 2.2 Million.
Qtrly Loss per Share Rmb 2.43.
Revenue is expected to be $1.52 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $1.64 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.